cequa
(cyclosporine)Sun Pharmaceutical Industries, Inc.
Usage: CEQUA ophthalmic solution is indicated for increasing tear production in patients with keratoconjunctivitis sicca (dry eye) as a calcineurin inhibitor immunosuppressant.
5 results
cyclosporine
(cyclosporine)Devatis Inc.Usage: Cyclosporine ophthalmic emulsion is indicated for increasing tear production in patients with keratoconjunctivitis sicca, particularly when tear production is suppressed due to ocular inflammation. It is not effective in patients already using topical anti-inflammatory drugs or punctal plugs.lacrisert
(hydroxypropyl cellulose)Bausch & Lomb IncorporatedUsage: LACRISERT is indicated for treating moderate to severe dry eye syndromes, including keratoconjunctivitis sicca, particularly in patients who do not respond adequately to artificial tears. It is also used for exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.restasis
(cyclosporine)Allergan, Inc.Usage: RESTASIS® ophthalmic emulsion is indicated for increasing tear production in patients with keratoconjunctivitis sicca, whose tear production is likely suppressed due to ocular inflammation. It is not effective in patients currently using topical anti-inflammatory drugs or punctal plugs.restasis multidose
(cyclosporine)Allergan, Inc.Usage: RESTASIS MULTIDOSE ophthalmic emulsion is indicated to increase tear production in patients with keratoconjunctivitis sicca, particularly when tear production is presumed suppressed due to ocular inflammation. It is not effective in patients currently using topical anti-inflammatory drugs or punctal plugs.